Safety and antitumor activity of apalutamide (ARN-509) in metastatic castration-resistant prostate cancer with and without prior abiraterone acetate and prednisone

Dana E. Rathkopf, Emmanuel S. Antonarakis, Neal D. Shore, Ronald F. Tutrone, Joshi J. Alumkal, Charles J. Ryan, Mansoor Saleh, Ralph J. Hauke, Rajesh Bandekar, Edna Chow Maneval, Carla J. De Boer, Margaret K. Yu, Howard I. Scher

    Research output: Contribution to journalArticlepeer-review

    58 Scopus citations

    Fingerprint Dive into the research topics of 'Safety and antitumor activity of apalutamide (ARN-509) in metastatic castration-resistant prostate cancer with and without prior abiraterone acetate and prednisone'. Together they form a unique fingerprint.

    Medicine & Life Sciences